WW

Q2 FY2026 EarningsQ2 FY2026 beat consensus on the top line with revenue of $162.3M vs. $159.1M expected, driven by 30.4% YoY growth in Clinical subscription revenue. Despite the revenue beat, gross margin of 70.3% slightly missed the 71.1% consensus due to a mix shift toward lower-margin Clinical services. Net income (GAAP) of $14.1M significantly exceeded the $6.6M consensus, aided by a $4.6M gain on debt extinguishment and a favorable tax benefit of $11.2M.